DSM Goes Biologic: The Next Frontier in Diagnosing Mental Illness
The DSM is moving toward integrating biology into psychiatric diagnoses for the first time, aiming to use biomarkers and neurobiology to supplement symptom-based criteria. While current biomarkers for mental illness are limited and environmental factors blur biological signals, recent advances offer promise: blood-based biomarkers for Alzheimer's disease, inflammatory markers like CRP that may identify treatment-responsive subtypes, and genetic risk scores that could feed into precision psychiatry. The shift acknowledges overlapping symptom clusters and subgroups within disorders, with the goal of more objective, personalized diagnoses in the future, even as clinicians recognize the complexity and remaining gaps before such biology-driven DSM criteria become standard practice.
